The recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value.
Sarah Bandy, PhD
Advertisement
Sarah Bandy, PharmD, PhD is a Manager, Value Evidence, AESARA Inc.
Articles by Sarah Bandy, PhD
Advertisement
Latest Updated Articles
HEOR: From Proving Product Value to Proving Its Own WorthPublished: March 6th 2025 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
Could DTC Programs Help Simplify the Drug-Pricing System?
3
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
4
AI Becomes Pharma’s New Operating System: Q&A with causaLens’ CEO and Co-Founder Darko Matovski
5
